Both in Pharmaceuticals
Ernexa Therapeutics vs Sunshine Biopharma
Over the past year ERNA returned −95.3% and SBFM returned −99.1%; their daily moves had a correlation of 0.02.
ERNA −95.3% SBFM −99.1%Growth of $1, one year, split-adjusted
| Metric | ERNA | SBFM |
|---|---|---|
| Price | $1.97 | $2.93 |
| Market cap | $2.3M | $2.2M |
| Today | −6.64% | −12.01% |
| 1 month | −33.4% | −78.7% |
| 6 months | −97.9% | −98.6% |
| Year to date | −93.4% | −98.8% |
| 1 year | −95.5% | −99.2% |
| Revenue growth (YoY) | — | −1.6% |
| Gross margin | — | 26.2% |
| Net margin | — | −16.9% |
| P/E (TTM) | — | — |
| Price / sales | — | 0.1× |
| Net cash | $5.0M | $13.7M |
| Dividend yield | — | — |
| Volatility (60d) | 79.7% | 896.6% |
| Short % of float | 2.1% | 5.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).